Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1990 1
1993 1
1995 1
1997 1
1999 2
2001 2
2002 6
2003 11
2004 15
2005 14
2006 13
2007 6
2008 12
2009 36
2010 41
2011 34
2012 24
2013 38
2014 37
2015 43
2016 36
2017 31
2018 26
2019 48
2020 33
2021 27
2022 18
2023 8
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 21047494

507 results

Results by year

Filters applied: . Clear all
Page 1
Erlotinib for the treatment of relapsed non-small cell lung cancer.
McLeod C, Bagust A, Boland A, Hockenhull J, Dundar Y, Proudlove C, Davis H, Green J, Macbeth F, Stevenson J, Walley T, Dickson R. McLeod C, et al. Health Technol Assess. 2009 Jun;13 Suppl 1:41-7. doi: 10.3310/hta13suppl1/07. Health Technol Assess. 2009. PMID: 19567213 Free article.
Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175): a systematic review and economic evaluation.
Greenhalgh J, Bagust A, Boland A, Dwan K, Beale S, Hockenhull J, Proudlove C, Dundar Y, Richardson M, Dickson R, Mullard A, Marshall E. Greenhalgh J, et al. Health Technol Assess. 2015 Jun;19(47):1-134. doi: 10.3310/hta19470. Health Technol Assess. 2015. PMID: 26134145 Free PMC article. Review.
Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation.
Brown T, Pilkington G, Bagust A, Boland A, Oyee J, Tudur-Smith C, Blundell M, Lai M, Martin Saborido C, Greenhalgh J, Dundar Y, Dickson R. Brown T, et al. Health Technol Assess. 2013 Jul;17(31):1-278. doi: 10.3310/hta17310. Health Technol Assess. 2013. PMID: 23886301 Free PMC article. Review.
507 results